Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes

By Arakawa T.   Tsuboi T.   Kishimoto A.   Sattabongkot J.   Suwanabun N.   Rungruang T.   Matsumoto Y.   Tsuji N.   Hisaeda H.   Stowers A.   Shimabukuro I.   Sato Y.   Torii M.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3143-3148

Elsevier

Access to resources Recommend Favorite

Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens

By Rogers W.O.   Gowda K.   Hoffman S.L.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3136-3144

Elsevier

Access to resources Recommend Favorite

Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies

By Ploton I.N.   Wizel B.   Viscidi R.   Kumar N.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1161-1169

Elsevier

Access to resources Recommend Favorite

Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials

By Zou L.   Miles A.P.   Wang J.   Stowers A.W.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1650-1657

Elsevier

Access to resources Recommend Favorite

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1 19 expressed in distinct bacterial vectors

By Cunha M.G.   Rodrigues M.M.   Soares I.S.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 385-396

Elsevier

Access to resources Recommend Favorite